(Q51839697)

English

The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. (English)

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

object named as

Evelyn Ullrich

4

0 references

Othmar G Engelhardt

1

object named as

Othmar G Engelhardt

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

author name string

Chris Boutell

2

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Anne Orr

3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Otto Haller

5

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Roger D Everett

6

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Experimental Cell Research

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

283

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

36-50

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

1

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Identification of three major sentrinization sites in PML

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Activation of androgen receptor function by a novel nuclear protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

SUMO-1 modification activates the transcriptional response of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Characterization of a novel serine/threonine kinase associated with nuclear bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

RanBP2 associates with Ubc9p and a modified form of RanGAP1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2802%2900025-3

7 January 2021

Identifiers

10.1016/S0014-4827(02)00025-3

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

1 reference

Europe PubMed Central

13 April 2018

http://europepmc.org/abstract/MED/12565818

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51839697&oldid=1373085154"